673 filings
Page 14 of 34
8-K
g92ffk9zahd67c
28 Apr 15
ANI Pharmaceuticals Schedules Conference Call for First Quarter 2015 Financial Results
12:00am
8-K
wwo47iv
16 Apr 15
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
sqbzr01y88 8z
7 Apr 15
ANI Pharmaceuticals Presents At 14th Annual Needham Healthcare Conference
12:00am
8-K
9w2yn12tc4je5
27 Feb 15
Regulation FD Disclosure
12:00am
EFFECT
5obcc
23 Feb 15
Notice of effectiveness
12:00am
8-K
n4a1ib6
20 Feb 15
Departure of Directors or Certain Officers
12:00am
POS AM
hva 8c770
20 Feb 15
Prospectus update (post-effective amendment)
12:00am
8-K
njmtavaejl tsy3ky
19 Feb 15
ANI Pharmaceuticals Reports Record Fourth Quarter and Full Year 2014 Financial Results
12:00am
8-K
ivnhktx6krlm509
12 Feb 15
ANI Pharmaceuticals Schedules Conference Call for Fourth Quarter and Full Year 2014 Financial Results
12:00am
CT ORDER
3l7vkrdy
4 Feb 15
Confidential treatment order
12:00am
8-K
6lc1ki h6nrw7
3 Feb 15
ANI Pharmaceuticals Announces Appointment of Dr. David Sullivan to VP of Quality Operations
12:00am
8-K
gezk0i9yr5ap2hm85
11 Dec 14
ANI Pharmaceuticals Presents At Oppenheimer 25th Annual Healthcare Conference
12:00am
8-K
zbw00t9xjs9fa5qwe
10 Dec 14
ANI Pharmaceuticals Announces Closing of 3.00% Convertible Senior Notes and Full Exercise of Over-Allotment Option
12:00am
424B5
l3t5hitbi7oc8
8 Dec 14
Prospectus supplement for primary offering
12:00am
8-K
lat6aezl
8 Dec 14
ANI Pharmaceuticals Announces Pricing of Upsized $125 Million Convertible Notes Offering
12:00am
FWP
ennayl
5 Dec 14
Free writing prospectus
12:00am
424B5
cjv8cvts
4 Dec 14
Prospectus supplement for primary offering
12:00am
8-K
ydrwq87
10 Nov 14
Regulation FD Disclosure
12:00am